America’s role in advancing science, investing in domestic manufacturing, and protecting public health is at a pivotal moment. Scientific discoveries are creating unprecedented opportunities, and the choices government agencies make today will determine how quickly those innovations reach patients. By modernizing how we develop and manufacture lifesaving therapies here at home, we can bet on ourselves and accelerate delivery to the people who need them most.

To do so, we must fundamentally rethink how medicines are developed, reviewed, and manufactured. The United States has prioritized rebuilding and securing domestic pharmaceutical manufacturing. Yet, despite this commitment, the existing regulatory framework continues to delay turning investments into tangible progress for patients.

T

See Full Page